Mumbai, Maharashtra, India
GST : 27AAHPM3187H1ZG
Verified
Add Review
Our Products
Estramustine Phosphate Capsules BP 140 mg is used in palliative therapy of metastatic or progressive prostate cancer. Estramustine appears to act as a relatively weak alkylating agent and imparts a weak estrogenic activity. The estrogenic portion of the molecule acts as a carrier to facilitate selective uptake of the drug into estrogen receptor-positive cells. Because of the selective steroidal uptake, the alkylating effect of the nitrogen mustard is enhanced in these cells. Estramustine phosphate is readily dephosphorylated during absorption, and the major metabolites in plasma are estramustine, the estrone analog, estradiol, and estrone.
India has many manufacturers who manufacture Estramustine Phosphate Capsules BP 140 mg .To know more contact us.
3s corporation is Supplier, Exporter , Wholesaler for Estramustine Phosphate Capsules BP 140 mg in India.
ADDITIONAL INFORMATION
Dose in Prostate Cancer
Adults
14 mg/kg/day (range, 10 to 16 mg/kg/day) in 3 to 4 divided doses for 30 to 90 days before assessing for continuation of therapy. Continue therapy as long as response is favorable.
GENERAL ADVICEAdminister with water 1 h or more before or 2 h after meals.
SIDE EFFECTS
Hypertension; CHF; edema; increased risk of cerebrovascular accident; MI, thrombosis.
CNSLethargy; emotional lability; insomnia.
DERMATOLOGICRash; pruritus; dry skin; easy bruising.
ENDOCRINEDecreased glucose tolerance; breast tenderness or enlargement.
GINausea; vomiting; diarrhea; anorexia; flatulence; elevated LFTs.
GENITOURINARYDecreased glucose tolerance; gonadal suppression; breast tenderness; breast enlargement.
HEMATOLOGICLeukopenia and thrombocytopenia have been reported in a small number of patients.
MUSCULOSKELETALLeg cramps.
RESPIRATORYDyspnea.
Iressa 250 mg (Gefitinib) tablet from AstraZeneca is a cancer chemotherapy prescription medication used for certain breast, lung and other cancers.It interferes with the growth of cancer cells and slows their growth and spread in the body. Iressa is mainly used in the treatment of non-small cell lung. Iressa may also be used for purposes other than those listed in this medication guide. It has a pack size of 30 tabs (3 strips of 10 tabs each).
ADDITIONAL INFORMATION
Dosage Information:
Iressa should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.
Take each dose of this medicine with a full glass of water.
Iressa can be taken with or without food.
Your doctor will determine the correct amount and frequency of treatment with Iressa depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.
It is important to take Iressa regularly to get the most benefit.
Your doctor may want you to have blood tests and other medical evaluations during treatment with Iressa to monitor progress and side effects.
Your healthcare provider will store this medicine as directed by the manufacturer. If you are storing Iressa at home, follow the directions provided by your healthcare provider.
Contact your doctor immediately if you experience any of the following serious side effects from Iressa:
Other, less serious Iressa side effects may be more likely to occur. Continue taking Iressa and talk to your doctor if you experience:
Dr Reddy’s Laboratories launched Peg-grafeel, Dr Reddy’s brand of pegfilgrastim in India. Peg-grafeel has been approved in India to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy with the exception of chronic myeloid leukaemia and myelodysplastic syndromes.
Pegfilgrastim is a pegylated long-lasting variant of filgrastim. One injection of pegfilgrastim can replace up to 14 injections of filgrastim, which must be administered daily. It can be administered once per chemotherapy cycle, providing convenience to the patient while eliminating many of the additional costs of treatment.Peg-grafeel is priced at an MRP of Rs.8, 865 and represents a breakthrough in the pricing of this complex molecule. It is priced at approximately 25 per cent of the originator brand in India, and is priced 95 per cent lower than the US price for pegfilgrastim
Eurepa Tablet (Repaglinide) from Torrent Pharma is an anti-diabetic medication prescribed to lower blood sugar (glucose) levels in individuals with type 2 (non-insulin dependent) diabetes. Repaglinide is used in combination with healthy diet and regular exercise. This oral medication helps control blood sugar by stimulating the pancreas to produce more insulin.
Glinate (Nateglinide) Tablet manufactured by Sun Pharma is used to control blood glucose levels in individuals with type 2 diabetes. This medicine may be used with diet and exercise. Nateglinide belongs to a class of drugs called meglitinides. By stimulating the pancreas to release insulin, Generic for Starlix regulates the amount of sugar levels in your blood.
Prandial (Voglibose) manufactured by Cipla is an oral antidiabetic medication used to lower postprandial blood glucose levels (postprandial hyperglycemia) in people with diabetes mellitus. It is an alpha-glucosidase inhibitor that delays the digestion and absorption of sugar.
Recommended Dosage – Discount Prescription Drug Voglibose
The dosage of Voglibose prescribed to each patient will vary. Always follow your physician’s instructions and/or the directions on the prescription drug label.
Adriamycin - Doxorubicin Injectable Suspension is an antineoplastic antibiotic. It is widely used to treat certain types of cancer. We are a certified Adriamycin - Doxorubicin Injectable Suspension Exporter and Supplier from Maharashtra (India). We make available Adriamycin - Doxorubicin Injectable Suspension in standard packing of 5 ML VIAL at reasonable price.
Warning : This medicine must be given slowly and directly into a vein (IV) through other intravenous (IV) fluids. Do not inject this medicine into the muscle (IM) or just beneath the skin (subcutaneously). If this medicine accidentally leaks into surrounding tissue, the skin and/or muscle may be severely damaged. Notify the doctor immediately if redness, pain, or swelling occur at (or around) the injection site. Doxorubicin may cause heart problems (including heart failure) or bone marrow suppression. Notify your doctor immediately if you develop an irregular heartbeat, trouble breathing, swelling of the hands or feet, easy bruising or bleeding, dry cough, or signs of infection such as fever, unusual fatigue, or persistent sore throat. Heart problems may occur during therapy or sometimes, months to years after receiving this medicine. The risk of developing heart problems varies depending on your dose and condition. Tell your doctor if you have liver problems since the dose should be decreased in this situation. Your doctor will closely monitor you while you are using this medicine. Some medicines or medical conditions may interact with this medicine. INFORM YOUR DOCTOR OR PHARMACIST of all prescription and over-the-counter medicine that you are taking. ADDITIONAL MONITORING OF YOUR DOSE OR CONDITION may be needed if you are taking cyclosporine, cyclophosphamide, digoxin, warfarin, or medicine for seizures. Inform your doctor of any other medical conditions, allergies, pregnancy, or breast-feeding. Contact your doctor or pharmacist if you have any questions or concerns about taking this medicine.
